Palace confident of FDA review process amid bribery claims vs Sinovac | Inquirer News

Palace confident of FDA review process amid bribery claims vs Sinovac

/ 02:27 PM December 10, 2020

MANILA, Philippines — Malacañang is confident that the country’s vaccine screening authorities will not fall into bribery amid reports that Sinovac, one of several COVID-19 vaccines being lined up for use in the Philippines, reportedly bought its way to get past Chinese regulators before.

Presidential spokesperson Harry Roque said President Duterte has full trust in Food and Drug Administration (FDA) chief Eric Domingo in ensuring that the country will only use efficient and safe coronavirus vaccines.

Article continues after this advertisement

“Consistent po tayo na papayagan lang natin magamit ang mga bakuna na napatunayang nang ligtas at mabisa laban sa COVID-19,” Roque said in his regular press briefing Thursday.

FEATURED STORIES

“Buong buo po ang tiwala ni Presidente kay Dr. Domingo, so pagdating po diyan sa allegations on bribery, tingin ko po hindi mangyayari iyan sa Pilipinas,” he added.

In a Dec. 4 report, US newspaper Washington Post said Sinovac Biotech had been found to have a record of bribing Chinese drug regulators to secure vaccine approvals, which had raised serious questions about its products’ safety.

Article continues after this advertisement

Health Secretary Francisco Duque III earlier said the FDA, as well as the vaccine experts panel, are “aware” of the report and will validate the veracity of the allegations against the Chinese drugmaker.

Article continues after this advertisement

FILE PHOTO: People work in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter

According to the report, Sinovac’s CEO admitted to giving more than $83,000 to a regulatory official from 2002 to 2011.

Article continues after this advertisement

“Those years corresponded to Sinovac’s breakout period when the biotech startup founded in 2001 was handpicked by Beijing officials to lead the development of vaccines for SARS, avian flu and swine flu,” Washington Post said.

Sinovac is currently seeking the approval of the FDA to conduct Phase 3 clinical trials here after passing the initial evaluation of the country’s vaccine experts panel. It has already started delivering vaccines to Indonesia.

Article continues after this advertisement

The government’s pandemic response chief implementer and vaccine czar Carlito Galvez Jr. earlier said Sinovac’s coronavirus vaccine may be the first to be rolled out in the country.

He also assured that Sinovac’s vaccine is safe as it utilizes the “classical inactivated virus platform.”

EDV
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: bribery, Coronavirus, COVID-19, Malacañang, NcoV, Philippines, Sinovac, Vaccines

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.